On 14 August, China Resources Sanjiu (“CR Sanjiu”) announced that it entered into a strategic cooperation agreement with Ryukakusan, a renowned Japanese pharmaceutical company that develops throat and swallowing products, at the 2019 China Pharmaceutical Enterprises Co-operation and Development Organization Summit. This was another major move by CR Sanjiu following its cross-border cooperation with Sanofi and Goodbaby.

Ryukakusan is one of the most popular throat and swallowing products in Japan. Taken without water and directly moisturizing the throat, Ryukakusan has been highly praised by Chinese consumers and tourists visiting Japan. Through this strategic cooperation, CR Sanjiu hopes to fully leverage the advantages of traditional pharmacies’ channels and explore new sales channels and marketing models, including the sales of China Resources’ supermarkets and other emerging online and offline channels. The Company will make joint efforts with Ryukakusan to explore new sales models such as influencer marketing. Through new types of marketing such as popular marketing, CR Sanjiu aims to empower traditional pharmacies so as to explore new retail terminals and enhance its brand building capabilities.